5:58 PM
 | 
Mar 03, 2014
 |  BC Extra  |  Financial News

Acadia planning $150 million follow-on

Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) proposed late Monday to raise up to $150 million in a follow-on...

Read the full 63 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >